Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

London pre-open: Stocks to rise ahead of non-farm payrolls report

(Sharecast News) - London stocks were set to rise at the open on Friday as investors eyed the latest US non-farm payrolls report, and continued to mull 75-basis point rate hikes by the Federal Reserve and the Bank of England this week.

The FTSE 100 was called to open 40 points higher at 7,228.

CMC Markets analyst Michael Hewson said: "It was another tough day for European and US markets yesterday in the wake of concerns that the Federal Reserve's aggressive stance on inflation will drive the global economy into recession, as the soaring US dollar exports an inflationary shock across the world.

"Asia markets have managed to stabilise somewhat with Chinese markets surging on more unsubstantiated reports that the Chinese government is looking at a reopening strategy.

"While the FTSE100 saw a positive session yesterday that was more to do with the weakness of the pound with the Bank of England once again delivering a muddled message when it comes to monetary policy."

As far as the payrolls report is concerned, Hewson said expectations are for jobs growth to 195,000, which would be the lowest number this year, while the unemployment rate is set to tick back up to 3.6%.

In corporate news, Morgan Advanced Materials lifted profit and revenue guidance as sales for the first nine months of the year rose 10.5%.

The company said it now expected full year organic constant-currency growth to be in the range 7-9%, above previous guidance, and adjusted operating profit to be marginally above the top end of current analysts' forecasts.

Drugmaker AstraZeneca said that its Beyfortus asset had received European Union approval for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns and infants.

AstraZeneca stated that Beyfortus was now the first and only single-dose RSV passive immunisation for the broad infant population, including those born healthy, at term or pre-term, or with specific health conditions.

Share this article

Related Sharecast Articles

London close: Stocks recoup some earlier losses
(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.
London midday: FTSE stays down; Auto Trader hit by downgrade
(Sharecast News) - London stocks were still in the red by midday on Friday, having taken their opening cue from a downbeat close on Wall Street.
London open: FTSE edges down after US losses; Landsec in focus
(Sharecast News) - London stocks edged lower in early trade on Friday following a downbeat close on Wall Street.
London pre-open: Stocks seen lower after Wall Street losses
(Sharecast News) - London stocks were set to fall at the open on Friday following a downbeat close on Wall Street.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.